Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation.

Anti-dsDNA antibodies Anti-dsDNA binding Autoimmune disease DNA relaxation Systemic lupus erythematosus Topoisomerase I

Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
28 Oct 2023
Historique:
received: 07 04 2023
accepted: 24 10 2023
medline: 30 10 2023
pubmed: 29 10 2023
entrez: 29 10 2023
Statut: epublish

Résumé

Topoisomerase I (topo I) is a highly conserved enzyme which is known to reduce torsional stress at double-stranded (ds) DNA. Torsional stress induced by supercoiling of dsDNA requires either very long dsDNA existing in genomic DNA or circulation as presented in plasmid DNA. To enable DNA relaxation, topo I induce a transient single-strand break followed by stress-relieving rotation of the released DNA strand. Our group found by serendipity that the topo I inhibitor irinotecan is able to suppress murine systemic lupus erythematosus (SLE), an autoimmune disease which is characterized by the existence of pathogenic anti-dsDNA antibodies (abs). As a possible mechanism we demonstrated in the absence of immunosuppression an increased binding of anti-dsDNA abs to long genomic or circulated plasmid dsDNA modified with topo I. Here we show that this effect requires active site tyrosine of topo I which is known to facilitate DNA relaxation activity. Moreover, topo I enhanced anti-dsDNA abs binding to short linear oligonucleotides down to a size of 42 bp. Since oligonucleotides of such length are devoid of torsional stress and relaxation respectively, our results suggest a new and unknown function for the enzyme topo I.

Identifiants

pubmed: 37898816
doi: 10.1186/s13104-023-06592-9
pii: 10.1186/s13104-023-06592-9
pmc: PMC10612351
doi:

Substances chimiques

anti-dsDNA autoantibody 0
DNA Topoisomerases, Type I EC 5.99.1.2
Oligonucleotides 0
Antibodies, Antinuclear 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

298

Informations de copyright

© 2023. The Author(s).

Références

Nature. 1996 May 2;381(6577):80-2
pubmed: 8609994
EMBO J. 1995 Nov 1;14(21):5399-409
pubmed: 7489729
Semin Oncol. 1998 Oct;25(5 Suppl 11):39-46
pubmed: 9786315
Arthritis Res Ther. 2016 Oct 22;18(1):243
pubmed: 27770825
Annu Rev Biochem. 2001;70:369-413
pubmed: 11395412
J Immunol. 2010 Feb 15;184(4):2175-82
pubmed: 20083657
Nat Rev Rheumatol. 2021 Sep;17(9):515-532
pubmed: 34345022
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6656-60
pubmed: 8393572
Arthritis Rheum. 2011 Dec;63(12):3918-30
pubmed: 22127708
Arthritis Rheumatol. 2021 Aug;73(8):1478-1488
pubmed: 33559345
J Autoimmun. 2023 Apr;136:103025
pubmed: 36996699
Front Immunol. 2018 Jul 05;9:1551
pubmed: 30026744
Arthritis Rheum. 2012 Apr;64(4):1215-26
pubmed: 22231479
Clin Immunol. 2016 May;166-167:38-47
pubmed: 27083935
N Engl J Med. 2004 Mar 4;350(10):971-80
pubmed: 14999109
Mol Cell Biol. 1996 Dec;16(12):6804-9
pubmed: 8943335
J Biol Chem. 2015 May 29;290(22):14068-76
pubmed: 25887397
Nat Commun. 2023 Feb 7;14(1):668
pubmed: 36750564
Scand J Rheumatol. 2022 May;51(3):237-240
pubmed: 34726116
Clin J Am Soc Nephrol. 2008 May;3(3):895-8
pubmed: 18287258
Chromosoma. 2005 Jul;114(2):75-85
pubmed: 15830206
Nucleic Acids Res. 1998 Jun 15;26(12):2963-70
pubmed: 9611242
N Engl J Med. 1968 Mar 7;278(10):533-8
pubmed: 4866347
Lancet. 2011 Feb 26;377(9767):721-31
pubmed: 21296403
Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808
pubmed: 22556106
Cancer Res. 1989 Sep 15;49(18):5077-82
pubmed: 2548710
Arthritis Rheumatol. 2015 Jul;67(7):1858-67
pubmed: 25779651
Arthritis Rheumatol. 2014 Aug;66(8):2259-69
pubmed: 24729466
J Clin Oncol. 2001 Mar 1;19(5):1501-18
pubmed: 11230497
Cancer Res. 1989 Nov 15;49(22):6318-23
pubmed: 2553253
Biochemistry. 1989 May 30;28(11):4629-38
pubmed: 2548584
Arthritis Rheum. 2013 Sep;65(9):2368-79
pubmed: 23740801

Auteurs

Manuela Frese-Schaper (M)

Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), a Leibniz Institute, Berlin, Germany.

Reinhard E Voll (RE)

Department of Rheumatology and Clinical Immunology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany.

Steffen Frese (S)

Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), a Leibniz Institute, Berlin, Germany. steffen.frese@email.de.
Department of Thoracic Surgery, AMEOS Klinikum Schönebeck, Köthener Str. 13, D-39218, Schönebeck, Germany. steffen.frese@email.de.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH